A Randomized-Controlled Trial to Examine the Effects of a Daily Probiotic Supplement on Common Symptoms of Menopause

NCT ID: NCT06148714

Last Updated: 2024-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2024-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Symptoms of menopause can significantly affect overall quality of life. It is hypothesized that probiotic supplements can reduce the severity of these symptoms. This 90-day randomized controlled trial will examine the effects of the Provitalize Natural Menopause Probiotic on weight loss, waist circumference, sleep, and symptoms of menopause including hot flashes, night sweats, mood swings, anxiety, fatigue and brain fog. Participants will take either the test product or a placebo daily. All participants will complete study-specific questionnaires and provide sleep data from their Fitbit at Baseline, Day 30, Day 60 and Day 90. At Baseline, Day 30, Day 60 and and Day 90, participants will also provide a bodyweight measurement and a waist circumference measurement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopause

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized-Controlled Trial
Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
This study will be triple-blinded in that the study participants, the study coordinators, and the data analysis team will be blinded to the intervention or product allocation. Only the sponsor will know which product contains the active ingredients. After the study analysis is complete, the allocation will be unblinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Provitalize Probiotic

Participants will take 2 capsules every morning on an empty stomach before their first meal of the day.

Group Type EXPERIMENTAL

Provitalize Natural Menopause Probiotic

Intervention Type DIETARY_SUPPLEMENT

Supplement containing a Probiotic blend of Bifidobacterium breve, Lactobacillus Gasseri, and Bifidobacterium animalis subsp. Lactis.

Placebo

Participants will take 2 capsules every morning on an empty stomach before their first meal of the day.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Placebo comparator containing Pure hydroxypropyl methylcellulose (HPmC) with food dye.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Provitalize Natural Menopause Probiotic

Supplement containing a Probiotic blend of Bifidobacterium breve, Lactobacillus Gasseri, and Bifidobacterium animalis subsp. Lactis.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Placebo comparator containing Pure hydroxypropyl methylcellulose (HPmC) with food dye.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women aged 45-65 years old
* Must experience hot flashes and/or night sweats at least once per day
* Must also be experiencing at least two symptoms of menopause, such as sleep disturbances, mood changes, fatigue and lack of energy, changes in sexual function, urinary changes, weight gain, or vaginal changes
* Can be either natural or surgical menopause
* Has not had a period in the last 12 consecutive months
* Willing to adhere to the study protocol for the duration of the study
* Willing to stop taking any other herbal remedies or supplements for the duration of the study
* Self-reports as "generally healthy"
* Has never taken Provitalize before
* No planned invasive medical procedures for the duration of the study or in the three weeks leading up to the study start

Exclusion Criteria

* Not experiencing hot flashes and/or night sweats at least once per day and two other symptoms of menopause such as sleep disturbances, mood changes, fatigue and lack of energy, changes in sexual function, urinary changes, irregular or absent periods, or vaginal changes
* Unwilling to stop taking any other herbal remedies or supplements for the duration of the study
* Current use of conventional hormone replacement therapies, or plan to start during the study duration
* Current use of hormonal birth control, or plan to start during the study duration
* Known allergies or hypersensitivities to any product ingredients
* Current or history of uterine fibroids, endometriosis, polycystic ovarian syndrome, or history of abnormal pap smear
* Anyone with any known severe allergies requiring the use of an epi-pen
* Unwilling to adhere to the study protocol
* Anyone living with uncontrolled or chronic health disorders, including oncological or psychiatric disorders
* Pregnant, breastfeeding or trying to conceive
* Currently taking a prescription sleep aid
Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Citruslabs

INDUSTRY

Sponsor Role collaborator

Maneuver Marketing

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Citruslabs

Santa Monica, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20379

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.